Merck
MRK
#64
Rank
NZ$418.36 B
Marketcap
NZ$167.49
Share price
-2.06%
Change (1 day)
-2.90%
Change (1 year)

P/S ratio for Merck (MRK)

P/S ratio as of December 2025 (TTM): 3.77

According to Merck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.66. At the end of 2025 the company had a P/S ratio of 3.05.

P/S ratio history for Merck from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.05-22.28%
20243.93-14.47%
20234.60-3.15%
20224.7519.38%
20213.97-13.85%
20204.61-6.41%
20194.935.25%
20184.6822.58%
20173.82-6.29%
20164.089.63%
20153.72-2.54%
20143.8214.68%
20133.3326.93%
20122.629.62%
20112.39-0.99%
20102.42-41.67%
20094.1453.66%
20082.69-48.35%
20075.2224.95%
20064.1832.42%
20053.151.89%
20043.09-32.21%
20034.5658.76%
20022.881.15%
20012.84

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.29-39.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.23 38.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.8 293.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.15-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.46-34.80%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
2.25-40.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
1.95-48.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
4.46 18.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
4.81 27.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
4.70 24.70%๐Ÿ‡บ๐Ÿ‡ธ USA